IMAC - International Market Access Consulting’s Post

ICYMI: Listen to Dr. Salvador Rico, CMO of Encoded Therapeutics Inc., discuss the company's gene therapy and overall program looking to tackle #DravetSyndrome https://lnkd.in/eZkjigEh #InternationalEpilepsyDay Dravet Syndrome Foundation

Are you developing a cell or gene therapy? Make sure you start planning early for your long-term follow-up too! To learn more about the scientific and operational considerations to optimize your #LTFU, check out this white paper developed by me and Delphine Saragoussi, MD, MScPH #RWE #CGT #LTFU https://lnkd.in/eT7UNcWv

Listen to Dr. Salvador Rico, CMO of Encoded Therapeutics Inc., discuss the company's gene therapy and overall program looking to tackle #DravetSyndrome #InternationalEpilepsyDay Dravet Syndrome Foundation

Headed to ASGCT this week? Stop by Booth #2235 to learn about our extensive commercial experience and regulatory track record to help advance your gene therapy to patients with more certainty. #ASGCT2024

Ever wondered about the intricate web of logistics behind #cellandgenetherapy #clinicaltrials? From sourcing specialized equipment to navigating regulatory requirements, every step is crucial in bringing innovative treatments to patients in need. We understand the nuances of these complex supply chains and have developed an end-to-end process to support your cell and gene therapy trial every step of the way. » https://bit.ly/3V8YOOd

Have you read our recently released target product profile (TPP) guide and want to learn more about how to develop an effective TPP for successful therapy adoption? Join our webinar on the 31st of January titled 'Developing a robust target product profile (TPP) for successful therapy adoption', where Cell and Gene Therapy Catapult’s experts in #MarketAccess, #RegulatoryAffairs and #NonClinical strategy will talk through the guide, discuss the value of a TPP and how to approach building one. Register now: https://buff.ly/3RqT2nC #TargetProductProfile #CellTherapies #GeneTherapies #TherapyDevelopers

What tangible patient outcomes is personalised medicine already bringing? As part of our latest Life Sciences in the Spotlight episode, Jason C. Foster examined the impacts that cell and gene therapies are already having and their potential future impacts. Take a listen below, and for the full conversation, check out the entire episode here: https://lnkd.in/d9KyPSCC #LifeSciences #PrecisionMedicine #PersonalisedMedicine #Pharma #PatientOutcomes

If you're curious how Theragent can support your cell therapy development, check out Brian Newsom's presentation on our latest capabilities and capacities. Thank you to Outsourced Pharma for hosting a great session! If you have any questions, send us a message to learn more about how Theragent can partner on your cell therapy at any stage. #CDMO #CGT #Manufacturing

Definitely joining this webinar!

Ultra-rapid Detection of Live Microbes